Clinical Trials · NCT00684905

Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Mayo Clinic
Enrollment
50
Start date
Apr 2000
Locations
1 site, United States
Primary endpoint
Feasibility
View Gonadorelin compound reference